Literature DB >> 32418495

Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.

Kosuke Inoue1, Deena Goldwater2,3, Matthew Allison4, Teresa Seeman1,3, Bryan R Kestenbaum5, Karol E Watson2.   

Abstract

Aldosterone is a steroid hormone regulating fluid and electrolyte homeostasis and is known to increase the risk of atherosclerosis. In this study, we examined the associations of serum aldosterone concentrations with subclinical atherosclerosis and all-cause mortality. This study included 948 adults aged 46 to 88 years from the MESA (Multi-Ethnic Study of Atherosclerosis) with measurements of serum aldosterone and plasma renin activity and not taking antihypertensive medications. Coronary calcification was longitudinally assessed using Agatston coronary artery calcium score from computed tomography scans. All-cause mortality was ascertained from the medical record. The average age (SD) was 62.3 (9.4) years and 53% were male. Among 700 subjects who had follow-up coronary artery calcium score (median follow-up of 6.4 years), higher aldosterone levels (per 100 pg/mL) were associated with higher coronary artery calcium (relative ratio, 1.17 [95% CI, 1.04-1.32]), with the association being stronger in individuals with suppressed plasma renin activity (≤0.5 μg/L/hr). Systolic or diastolic blood pressure mediated around 45% of the total effect of aldosterone on coronary artery calcium. Over a median follow-up of 12.5 years (120 deaths identified among 948 subjects), aldosterone was associated with the increased risk of all-cause mortality when plasma renin activity was suppressed; hazard ratio per 100 pg/mL, 1.70 (95% CI, 1.10-2.63). In this study, we found that higher aldosterone levels were associated with the increased risk of subclinical coronary atherosclerosis and all-cause mortality particularly when renin was suppressed. Our findings indicate the importance of aldosterone levels (even within the reference range) with respect to the cardiovascular system and overall health.

Entities:  

Keywords:  aldosterone; atherosclerosis; blood pressure; hypertension; mortality; renin

Mesh:

Substances:

Year:  2020        PMID: 32418495     DOI: 10.1161/HYPERTENSIONAHA.120.15006

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

2.  Positive Association Between Plasma Aldosterone Concentration and White Matter Lesions in Patients With Hypertension.

Authors:  Yujuan Yuan; Nanfang Li; Yan Liu; Qing Zhu; Mulalibieke Heizhati; Weiwei Zhang; Xiaoguang Yao; Deilian Zhang; Qin Luo; Menghui Wang; Guijuan Chang; Mei Cao; Keming Zhou; Lei Wang; Junli Hu; Nuerguli Maimaiti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-18       Impact factor: 5.555

3.  Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism.

Authors:  Marta Kantauskaite; Katharina Bolten; Matthias Boschheidgen; Claudia Schmidt; Thilo Kolb; Kai Uwe Eckardt; Andreas Pasch; Lars Schimmöller; Lars C Rump; Jakob Voelkl; Johannes Stegbauer
Journal:  Front Cardiovasc Med       Date:  2022-01-24

4.  Heightened Cardiovascular Risk in Hypertension Associated With Renin-Independent Aldosteronism Versus Renin-Dependent Aldosteronism: A Collaborative Study.

Authors:  Jinbo Hu; Hang Shen; Peiqi Huo; Jun Yang; Peter J Fuller; Kanran Wang; Yi Yang; Linqiang Ma; Qingfeng Cheng; Lilin Gong; Wenwen He; Ting Luo; Mei Mei; Yue Wang; Zhipeng Du; Rong Luo; Jun Cai; Qifu Li; Ying Song; Shumin Yang
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 6.106

Review 5.  Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.

Authors:  Anand Vaidya; Robert M Carey
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

6.  Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.

Authors:  Kosuke Inoue; Takumi Kitamoto; Yuya Tsurutani; Jun Saito; Masao Omura; Tetsuo Nishikawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

Review 7.  Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives.

Authors:  Daniela Maria Tanase; Alina Georgiana Apostol; Claudia Florida Costea; Claudia Cristina Tarniceriu; Ionut Tudorancea; Minela Aida Maranduca; Mariana Floria; Ionela Lacramioara Serban
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.